Drug intelligence / Profile preview

Zhengru Patch

Development stage: Unknown
Lead developer: 奇正藏药
Administration: Topical

Overview

Zhengru Patch is a topical Tibetan medicine developed by Gansu Qizheng Tibetan Medicine for the treatment of mammary gland hyperplasia. It is formulated based on traditional Tibetan medical principles to treat 'Nucuo disease,' which corresponds to the liver-qi stagnation and phlegm coagulation pattern in Traditional Chinese Medicine (TCM). The patch is applied topically to the breast area to alleviate symptoms such as pain and nodules. It has been evaluated in a randomized, double-blind, placebo-controlled Phase 2 clinical trial in China.

Brand names: Zhengru Patch
Other names: 正乳贴Zhengru Tie

Beyond the preview

Go deeper on Zhengru Patch.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhengru Patch.

Explore the full profile